21 CFR Subpart C
Labeling
June 25, 2020
§
341.70
Labeling of OTC drug products containing ingredients that are used for treating concurrent symptoms (in either a single-ingredient or combination drug product)
§
341.72
Labeling of antihistamine drug products
§
341.74
Labeling of antitussive drug products
§
341.76
Labeling of bronchodilator drug products
§
341.78
Labeling of expectorant drug products
§
341.80
Labeling of nasal decongestant drug products
§
341.85
Labeling of permitted combinations of active ingredients
§
341.90
Professional labeling
Tried the LawStack mobile app?
Join thousands and try LawStack mobile for FREE today.
- Carry the law offline, wherever you go.
- Download CFR, USC, rules, and state law to your mobile device.
